A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV).
Many HIV clinics with poor IT-infrastructure are unable to report data on individuals in care with HIV, on antiretroviral treatment (ART) and virologically suppressed (VS), with the aim of monitoring the HIV Continuum of Care to estimate efficacy of HIV treatment programmes. We developed an estimati...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316794 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540209581916160 |
|---|---|
| author | Dorthe Raben Marie L Jakobsen Jamina Trajanovska Justyna Kowalska Anna Vassilenko Snezana Dragas Arjan Harxhi Gordana Dragovic Nadine J Jaschinski Bastian Neesgaard Klaus Hjorth-Larsen Harmony Garges Joel Gallant Jens D Lundgren Andrew Philips Valentina Cambiano Yazdan Yazdanpanah Amanda Mocroft |
| author_facet | Dorthe Raben Marie L Jakobsen Jamina Trajanovska Justyna Kowalska Anna Vassilenko Snezana Dragas Arjan Harxhi Gordana Dragovic Nadine J Jaschinski Bastian Neesgaard Klaus Hjorth-Larsen Harmony Garges Joel Gallant Jens D Lundgren Andrew Philips Valentina Cambiano Yazdan Yazdanpanah Amanda Mocroft |
| author_sort | Dorthe Raben |
| collection | DOAJ |
| description | Many HIV clinics with poor IT-infrastructure are unable to report data on individuals in care with HIV, on antiretroviral treatment (ART) and virologically suppressed (VS), with the aim of monitoring the HIV Continuum of Care to estimate efficacy of HIV treatment programmes. We developed an estimation-tool, ESTIHIV, and determined the minimal data required for a random sample, to produce representative estimates, with a specified level of precision, of people with HIV on ART and VS. For proof of concept, 8852 HIV positive persons from seven clinics in seven different countries, with a follow-up visit during 2017, were included. Of those, 93.8% were on ART (95% CI 93.3-94.2) and 76.7% were VS (95% CI 75.8-77.6). In 2022, we tested the tool in the RESPOND Cohort for all countries with more than 100 participants under follow-up in 2019. We included 26,426 HIV positive persons from clinics in 27 countries, 97.8% (95% CI 97.6-98.0) were on ART and 91.5% were VS (95% CI 91.2-91.8%). There was good agreement between the RESPOND country estimates of ART and VS and the estimations using a random sample calculated in ESTIHIV. With ESTIHIV, clinics can produce a reliable estimate in figures for reporting and for monitoring the effectiveness of care in their clinics. |
| format | Article |
| id | doaj-art-c84a36d63aed4403bc0ee3db904452ba |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-c84a36d63aed4403bc0ee3db904452ba2025-02-05T05:31:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031679410.1371/journal.pone.0316794A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV).Dorthe RabenMarie L JakobsenJamina TrajanovskaJustyna KowalskaAnna VassilenkoSnezana DragasArjan HarxhiGordana DragovicNadine J JaschinskiBastian NeesgaardKlaus Hjorth-LarsenHarmony GargesJoel GallantJens D LundgrenAndrew PhilipsValentina CambianoYazdan YazdanpanahAmanda MocroftMany HIV clinics with poor IT-infrastructure are unable to report data on individuals in care with HIV, on antiretroviral treatment (ART) and virologically suppressed (VS), with the aim of monitoring the HIV Continuum of Care to estimate efficacy of HIV treatment programmes. We developed an estimation-tool, ESTIHIV, and determined the minimal data required for a random sample, to produce representative estimates, with a specified level of precision, of people with HIV on ART and VS. For proof of concept, 8852 HIV positive persons from seven clinics in seven different countries, with a follow-up visit during 2017, were included. Of those, 93.8% were on ART (95% CI 93.3-94.2) and 76.7% were VS (95% CI 75.8-77.6). In 2022, we tested the tool in the RESPOND Cohort for all countries with more than 100 participants under follow-up in 2019. We included 26,426 HIV positive persons from clinics in 27 countries, 97.8% (95% CI 97.6-98.0) were on ART and 91.5% were VS (95% CI 91.2-91.8%). There was good agreement between the RESPOND country estimates of ART and VS and the estimations using a random sample calculated in ESTIHIV. With ESTIHIV, clinics can produce a reliable estimate in figures for reporting and for monitoring the effectiveness of care in their clinics.https://doi.org/10.1371/journal.pone.0316794 |
| spellingShingle | Dorthe Raben Marie L Jakobsen Jamina Trajanovska Justyna Kowalska Anna Vassilenko Snezana Dragas Arjan Harxhi Gordana Dragovic Nadine J Jaschinski Bastian Neesgaard Klaus Hjorth-Larsen Harmony Garges Joel Gallant Jens D Lundgren Andrew Philips Valentina Cambiano Yazdan Yazdanpanah Amanda Mocroft A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV). PLoS ONE |
| title | A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV). |
| title_full | A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV). |
| title_fullStr | A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV). |
| title_full_unstemmed | A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV). |
| title_short | A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV). |
| title_sort | simple tool to evaluate the effectiveness of hiv care for settings with gaps in data availability estihiv |
| url | https://doi.org/10.1371/journal.pone.0316794 |
| work_keys_str_mv | AT dortheraben asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT marieljakobsen asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT jaminatrajanovska asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT justynakowalska asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT annavassilenko asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT snezanadragas asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT arjanharxhi asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT gordanadragovic asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT nadinejjaschinski asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT bastianneesgaard asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT klaushjorthlarsen asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT harmonygarges asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT joelgallant asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT jensdlundgren asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT andrewphilips asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT valentinacambiano asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT yazdanyazdanpanah asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT amandamocroft asimpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT dortheraben simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT marieljakobsen simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT jaminatrajanovska simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT justynakowalska simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT annavassilenko simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT snezanadragas simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT arjanharxhi simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT gordanadragovic simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT nadinejjaschinski simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT bastianneesgaard simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT klaushjorthlarsen simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT harmonygarges simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT joelgallant simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT jensdlundgren simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT andrewphilips simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT valentinacambiano simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT yazdanyazdanpanah simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv AT amandamocroft simpletooltoevaluatetheeffectivenessofhivcareforsettingswithgapsindataavailabilityestihiv |